Narrow search
Showing 1 - 10 of 199
Cover Image
The Gift of a Lifetime : The Hospital, Modern Medicine, and Mortality
Hollingsworth, Alex; Karbownik, Krzysztof; Thomasson, … - 2022
of the hospital from a fringe institution to one essential to the practice of medicine. Despite the central role of …. In this paper, we explore how access to the hospital and modern medicine affects mortality. We do so by leveraging a … combination of novel data and a unique quasi-experiment: a large-scale hospital modernization program introduced by The Duke …
Persistent link: https://www.econbiz.de/10014241607
Cover Image
Moral Hazard in Drug Purchases
Harju, Jarkko; Verho, J - 2023
We study the moral hazard effects of the drug copayment threshold in Finland using detailed prescription drug purchase data. The analysis reveals that the average drug costs increase discontinuously by 17% at the threshold above which out-of-pocket drug costs decrease substantially. Our results...
Persistent link: https://www.econbiz.de/10014347995
Cover Image
Pharmaceutical Prices : The Impact of the Launch Strategy - An Analysis of German Data
Böhler, Yvonne-Beatrice - 2019
pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012860771
Cover Image
Pricing the Pharmaceuticals When the Ability to Pay Differs : Taking Vertical Equity Seriously
Kanniainen, Vesa - 2020
A non-trivial fraction of people cannot afford to buy pharmaceutical products at unregulated market prices. Therefore, the paper analyzes the public insurance of the pharmaceutical products in terms of price controls and the socially optimal third-degree price discrimination. It characterizes...
Persistent link: https://www.econbiz.de/10012843430
Cover Image
The Effect of Bargaining Power Determinants on Pharmaceutical Prices
Linde, Sebastian - 2020
This paper provides insights into the determinants of bargaining power and how they affect drug prices. Our data show that drug prices vary across buyers and time periods. We estimate a structural bargaining model where drug suppliers and buyers engage in bilateral bargaining over drug prices....
Persistent link: https://www.econbiz.de/10012845687
Cover Image
The Patent Buyout Price for Human Papilloma Virus (HPV) Vaccine and the Ratio of R&D Costs to the Patent Value
Songane, Mario - 2020
Human papillomavirus (HPV) is responsible for almost all of the 570,000 new cases of cervical cancer and approximately 311,000 deaths per year. HPV vaccination is an integral component of the World Health Organization's (WHO) global strategy to fight the disease. However, high vaccine prices...
Persistent link: https://www.econbiz.de/10012825394
Cover Image
The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries : A Two-Way Fixed-Effects Analysis
Lichtenberg, Frank R. - 2019
, and that the reduction in hospital cost from the use of newer drugs was considerably greater than the innovation … in each country and from each disease. The number of hospital discharges and days of care in 2015 is significantly … estimated reduction in 2015 hospital expenditure that may be attributable to post-1981 drug launches was 5.3 times as large as …
Persistent link: https://www.econbiz.de/10012889758
Cover Image
Dynamic Mergers Effects on R&D Investments and Drug Development Across Research Phases in the Pharmaceutical Industry
Siebert, Ralph - 2020
Pharmaceutical firms spend increasing amounts in mergers and acquisitions (M&As), which raises the question of whether sufficient investment is left after mergers to further develop firms' internal drug development capability. We evaluate the effects of M&As on firms' post-merger R&D investments...
Persistent link: https://www.econbiz.de/10012833741
Cover Image
Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform
Brekke, Kurt Richard; Canta, Chiara; Straume, Odd Rune - 2022
Policy makers use reference pricing to curb pharmaceutical expenditures by reducing coverage of expensive branded drugs. In a theoretical analysis we show that the net effect of reference pricing is generally ambiguous when accounting for entry by generic producers. Reference pricing shifts...
Persistent link: https://www.econbiz.de/10014080046
Cover Image
How Does the Vaccine Approval Procedure Affect COVID-19 Vaccination Intentions?
Angerer, Silvia; Glätzle-Rützle, Daniela; … - 2022
Peoples’ willingness to vaccinate is critical to combating the COVID-19 pandemic. We devise a representative experiment to study how the design of the vaccine approval procedure affects public attitudes towards vaccination. Compared to an Emergency Use Authorization, choosing the more thorough...
Persistent link: https://www.econbiz.de/10013292647